HEALTH CARE ULTRASECTOR PROFUND
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-8.3%
1 yr return
13.7%
3 Yr Avg Return
2.7%
5 Yr Avg Return
1.6%
Net Assets
$9.97 M
Holdings in Top 10
53.6%
52 WEEK LOW AND HIGH
$83.8
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 2.76%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$15,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
HCPSX - Profile
Distributions
- YTD Total Return -8.3%
- 3 Yr Annualized Total Return 2.7%
- 5 Yr Annualized Total Return 1.6%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -1.57%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Other
Fund Details
-
Legal NameHEALTH CARE ULTRASECTOR PROFUND
-
Fund Family NameProFunds
-
Inception DateJun 19, 2000
-
Shares OutstandingN/A
-
Share ClassS
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerMichael Neches
Fund Description
The Fund invests in financial instruments that ProFund Advisors believes, in combination, should produce daily returns consistent with the Daily Target.The Index is designed to measure the performance of health care companies included in the S&P 500 Index. The S&P 500 Index is designed to measure the performance of 500 of the largest companies listed and domiciled in the U.S. The Index includes health care companies in the following industries according to the Global Industry Classification Standard (GICS): health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. These companies are then weighted based on market capitalization. The Index’s composition and the assigned weights are reevaluated every September with additional weight adjustments in March, June, and December. The Index is constructed and maintained by S&P Dow Jones Indices LLC. More information about the Index can be found using the Bloomberg ticker symbol “IXV.” Under normal circumstances, the Fund will obtain leveraged exposure to at least 80% of its total assets in components of the Index or in instruments with similar economic characteristics.The Fund will invest principally in the financial instruments listed below.●Equity Securities — Common stock issued by public companies.●Derivatives — Financial instruments whose value is derived from the value of an underlying asset or rate, such as stocks, bonds, exchange-traded funds, interest rates or indexes. The Fund invests in derivatives (e.g. swap agreements) in order to gain leveraged exposure to theIndex. These derivatives principally include:○Swap Agreements — Contracts entered into primarily with major global financial institutions for a specified period ranging from a day to more than one year. In a standard swap transaction, two parties agree to exchange or “swap” payments based on the change in value of an underlying asset or benchmark. For example, two parties may agree to exchange the return (or differentials in rates of returns) earned or realized on a particular investment or instrument.●Money Market Instruments — The Fund expects that any cash balances maintained in connection with its use of derivatives will typically be held in high quality, short-term money market instruments, for example:○U.S. Treasury Bills — U.S. government securities that have initial maturities of one year or less, and are supported by the full faith and credit of the U.S. government.○Repurchase Agreements — Contracts in which a seller of securities, usually U.S. government securities or other money market instruments, agrees to buy the securities back at a specified time and price.ProFund Advisors uses a mathematical approach to investing in which it determines the type, quantity and mix of investment positions that it believes, in combination, the Fund should hold to produce daily returns consistent with the Daily Target. For these purposes a day is measured from the time of one net asset value (“NAV”) calculation to the next. The Fund seeks to remain fully invested at all times in financial instruments that, in combination, provide leveraged exposure consistent with the investment objective, without regard to market conditions, trends or direction. However, the Fund may invest in or gain exposure to only a representative sample of the securities in the Index or to securities not contained in the Index or in financial instruments, with the intent of obtaining leveraged exposure consistent with the investment objective. The Fund seeks to rebalance its portfolio each day so that its exposure to the Index is consistent with the Daily Target. The Index’s movements during the day will affect whether the Fund’s portfolio needs to be rebalanced. For example, if the Index has risen on a given day, net assets of the Fund should rise (assuming there were no share redemptions). As a result, the Fund’s exposure will need to be increased. Conversely, if the Index has fallen on a given day, net assets of the Fund should fall (assuming there were no shares issued). As a result, the Fund’s exposure will need to be decreased.Please see “Investment Objectives, Principal Investment Strategies and Related Risks” in the Fund’s Prospectus for additional details.
Read More
HCPSX - Performance
Return Ranking - Trailing
| Period | HCPSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -8.3% | -37.8% | 596.7% | 89.24% |
| 1 Yr | 13.7% | -33.1% | 2312.2% | 81.65% |
| 3 Yr | 2.7%* | -11.4% | 136.8% | 94.30% |
| 5 Yr | 1.6%* | -44.2% | 68.9% | 72.15% |
| 10 Yr | 8.2%* | -36.9% | 62.0% | 72.11% |
* Annualized
Return Ranking - Calendar
| Period | HCPSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 14.9% | -41.2% | 466.0% | 58.23% |
| 2024 | -2.3% | -74.1% | 139.4% | 77.85% |
| 2023 | -2.3% | -56.9% | 257.9% | 83.54% |
| 2022 | -11.5% | -91.0% | 124.5% | 9.49% |
| 2021 | 32.6% | -79.4% | 168.2% | 46.84% |
Total Return Ranking - Trailing
| Period | HCPSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -8.3% | -37.8% | 596.7% | 89.24% |
| 1 Yr | 13.7% | -33.1% | 2312.2% | 81.65% |
| 3 Yr | 2.7%* | -11.4% | 136.8% | 94.30% |
| 5 Yr | 1.6%* | -44.2% | 68.9% | 72.15% |
| 10 Yr | 8.2%* | -36.9% | 62.0% | 72.11% |
* Annualized
Total Return Ranking - Calendar
| Period | HCPSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 14.9% | -40.4% | 478.4% | 67.72% |
| 2024 | -2.3% | -73.1% | 139.6% | 81.65% |
| 2023 | -2.3% | -55.8% | 259.6% | 84.81% |
| 2022 | -11.5% | -91.0% | 130.7% | 9.49% |
| 2021 | 32.6% | -79.4% | 168.2% | 53.80% |
NAV & Total Return History
HCPSX - Holdings
Concentration Analysis
| HCPSX | Category Low | Category High | HCPSX % Rank | |
|---|---|---|---|---|
| Net Assets | 9.97 M | 2.58 M | 31.3 B | 83.83% |
| Number of Holdings | 69 | 4 | 1969 | 41.98% |
| Net Assets in Top 10 | 20.3 M | 1.13 M | 14.3 B | 59.88% |
| Weighting of Top 10 | 53.59% | 11.4% | 142.8% | 56.17% |
Top 10 Holdings
- Eli Lilly Company 12.31%
- Johnson Johnson 8.18%
- AbbVie, Inc. 5.89%
- SOCIETE' GENERALE 3.55 , 2/02/2026 5.12%
- NATWEST MARKETS PLC 3.53 , 2/02/2026 4.09%
- Merck Company, Inc. 4.09%
- HSBC SECURITIES (USA), INC. 3.55 , 2/02/2026 3.93%
- UnitedHealth Group, Inc. 3.89%
- Thermo Fisher Scientific, Inc. 3.25%
- Abbott Laboratories 2.84%
Asset Allocation
| Weighting | Return Low | Return High | HCPSX % Rank | |
|---|---|---|---|---|
| Stocks | 83.61% | 0.00% | 166.59% | 14.20% |
| Other | 16.28% | -6.90% | 99.99% | 51.23% |
| Cash | 0.11% | 0.00% | 99.57% | 83.33% |
| Preferred Stocks | 0.00% | 0.00% | 2.01% | 80.25% |
| Convertible Bonds | 0.00% | 0.00% | 0.32% | 80.25% |
| Bonds | 0.00% | 0.00% | 30.76% | 80.25% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | HCPSX % Rank | |
|---|---|---|---|---|
| Healthcare | 99.58% | 0.00% | 100.00% | 5.60% |
| Basic Materials | 0.42% | 0.00% | 100.00% | 55.20% |
| Utilities | 0.00% | 0.00% | 100.00% | 86.40% |
| Technology | 0.00% | 0.00% | 100.00% | 90.40% |
| Real Estate | 0.00% | 0.00% | 100.00% | 87.20% |
| Industrials | 0.00% | 0.00% | 100.00% | 92.00% |
| Financial Services | 0.00% | 0.00% | 100.00% | 90.40% |
| Energy | 0.00% | 0.00% | 100.00% | 88.00% |
| Communication Services | 0.00% | 0.00% | 100.00% | 89.60% |
| Consumer Defense | 0.00% | 0.00% | 52.46% | 89.60% |
| Consumer Cyclical | 0.00% | 0.00% | 94.15% | 90.40% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | HCPSX % Rank | |
|---|---|---|---|---|
| US | 83.61% | 0.00% | 166.59% | 12.96% |
| Non US | 0.00% | 0.00% | 20.00% | 80.25% |
HCPSX - Expenses
Operational Fees
| HCPSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 2.76% | 0.07% | 5.63% | 8.86% |
| Management Fee | 0.75% | 0.00% | 0.95% | 62.87% |
| 12b-1 Fee | 1.00% | 0.00% | 1.00% | 98.43% |
| Administrative Fee | N/A | 0.03% | 0.25% | 42.11% |
Sales Fees
| HCPSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 4.75% | 4.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| HCPSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| HCPSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 266.00% | 78.10% |
HCPSX - Distributions
Dividend Yield Analysis
| HCPSX | Category Low | Category High | HCPSX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 18.26% | 98.20% |
Dividend Distribution Analysis
| HCPSX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Other | Annually | Monthly | Annual |
Net Income Ratio Analysis
| HCPSX | Category Low | Category High | HCPSX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -1.57% | -2.77% | 2.92% | 87.97% |
Capital Gain Distribution Analysis
| HCPSX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 20, 2017 | $4.439 | CapitalGainShortTerm |
| Dec 20, 2017 | $1.370 | CapitalGainLongTerm |
| Dec 15, 2014 | $0.601 | CapitalGainShortTerm |
| Dec 30, 2008 | $0.004 | OrdinaryDividend |
| Dec 28, 2006 | $0.006 | OrdinaryDividend |
HCPSX - Fund Manager Analysis
Managers
Michael Neches
Start Date
Tenure
Tenure Rank
Oct 01, 2013
8.67
8.7%
Michael Neches joined ProShare Advisors in 2000, and presently serves as a Senior Portfolio Manager. He previously served as the Senior Portfolio Manager responsible for the company’s commodities desk for two years, as a Portfolio Manager and team lead, as an Associate Portfolio Manager and as a Portfolio Analyst. Mr. Neches earned a Bachelor of Science in Finance from the University of Maryland, College Park and an MBA from Georgetown University.
Tarak Davé
Start Date
Tenure
Tenure Rank
Apr 30, 2018
4.09
4.1%
Tarak Dave ProFund Advisors LLC: Portfolio Manager since March 2018, Associate Portfolio Manager from November 2015 to March 2018, Senior Portfolio Analyst from May 2014 to October 2015 and Portfolio Analyst from April 2011 to April 2014.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 1.79 | 28.9 | 9.84 | 8.67 |